Investors got a shock when Lucid announced plans to sell shares to raise money, even as its production and delivery numbers ...
In a report released today, Michael Matson from Needham maintained a Buy rating on Lucid Diagnostics (LUCD – Research Report), with a ...
Analysts expect Lucid Diagnostics to report an earnings per share (EPS) of $-0.23. Investors in Lucid Diagnostics are eagerly ...
At the time, Lucid looked poised to fill a gap in the market. Like Tesla, it was a fresh, pure-play EV brand without much ...
Ben Kallo, an analyst from Robert W. Baird, reiterated the Hold rating on Lucid Group (LCID – Research Report). The associated price ...
Despite anticipated revenue growth, Lucid's high price-to-sales ratio makes it an expensive stock, especially compared to ...
Should you invest $1,000 in Lucid Group right now? Before you buy stock in Lucid Group, consider this: The Motley Fool Stock ...
Rivian stock continues its bearish slide, with key indicators pointing to further downside. Lucid struggles with oversold signals; the $1.75B raise shows they’re trying to stay afloat. As they ...